Connect with us

Business

Why this top broker expects CSL shares to surge 26%

Published

on

ADVERTISEMENT

Image source: Getty Images

CSL Ltd (ASX: CSL) shares look well-placed to shake-off the past year’s decline and charge higher into 2026.

That’s according to Morgans Financial, which labelled the S&P/ASX 200 Index (ASX: XJO) biotech stock “materially undervalued”.

CSL shares closed down 0.62% on…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending